Ivoxel (Mometasone Furoate)

Mometasone furoate binds to glucocorticoid receptors inside skin cells, modulating gene transcription. This reduces the production of inflammatory mediators, limits immune‑cell activity, and slows skin cell proliferation, leading to decreased redness, swelling, and itching.

The dosage of Ivoxel is determined by the prescribing clinician based on the severity of the skin condition, the area to be treated, patient age, and other clinical factors. Patients should follow the exact instructions provided on the prescription label.

The safety of topical mometasone furoate in pregnancy and lactation has not been definitively established. Healthcare providers should weigh potential benefits against possible risks and consider alternative therapies when appropriate.

To request Ivoxel, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ivoxel (mometasone furoate) is a high‑potency topical corticosteroid, offering strong anti‑inflammatory effects with once‑daily application in many cases. Compared with lower‑potency steroids, it may achieve faster symptom control but also carries a higher risk of local side effects if used improperly.

Store Ivoxel at room temperature, below 25 °C, in its original container. Keep it away from moisture, direct sunlight, and excessive heat to maintain product stability.

Ivoxel is applied topically to the affected skin area. A thin layer should be spread gently and evenly, usually once daily or as directed by the prescriber. Hands should be washed before and after application, and contact with eyes should be avoided.

Serious risks include skin atrophy, telangiectasia, hypopigmentation, secondary skin infections, and systemic effects such as adrenal suppression when large areas are treated for prolonged periods. Patients should report any unusual skin changes or systemic symptoms to their healthcare provider promptly.

Ivoxel should not be used by individuals with known hypersensitivity to mometasone furoate or any formulation excipients, on untreated fungal, bacterial, or viral skin infections, or on extensive broken skin without medical supervision. Children under two years of age should only use it if specifically prescribed.